Nature of expenses - Research and Development Expense (Details) - CAD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Nature of expenses | ||
| Research and development expenses | $ 13,466,234 | $ 15,505,346 |
| Amortization of intangible asset | ||
| Nature of expenses | ||
| Research and development expenses | 55,795 | 55,795 |
| Preclinical development | ||
| Nature of expenses | ||
| Research and development expenses | 726,790 | 2,085,692 |
| Chemistry, manufacturing and controls | ||
| Nature of expenses | ||
| Research and development expenses | 3,391,560 | 1,571,048 |
| Licensing and patent legal fees | ||
| Nature of expenses | ||
| Research and development expenses | 449,183 | 535,066 |
| Clinical and regulatory | ||
| Nature of expenses | ||
| Research and development expenses | 2,924,649 | 5,845,332 |
| Salaries and benefits | ||
| Nature of expenses | ||
| Research and development expenses | 4,356,192 | 3,702,721 |
| Stock-based compensation | ||
| Nature of expenses | ||
| Research and development expenses | 1,128,814 | 1,003,970 |
| Other research and development | ||
| Nature of expenses | ||
| Research and development expenses | $ 433,249 | $ 705,722 |